A PET/CT scan is a safe, painless, non-invasive imaging procedure that combines two powerful technologies:
By integrating both technologies, physicians get a complete picture: where a tumor is located and how active or aggressive it may be, all in one session. This approach makes it easier to detect various cancers including breast, melanoma, lymphoma, lung and more.
Benefits of PET/CT Imaging:
Before PET/CT, separate PET and CT scans were taken, and physicians had to manually match the images. This often led to inaccuracies, delays, and unnecessary procedures. The combined PET/CT scan eliminates those issues.
Cancer Care Northwest is home to the GE Discovery IQ 4-Ring PET/CT Scanner, the most sensitive imaging technology available today. This sophisticated scanner not only produces pictures that show the location and nature of the tumor, but it also takes four-dimensional (4D) images that capture a tumor in motion.
Our PET/CT scanner is the busiest scanner in the Inland Northwest and is located within our South Spokane Treatment Center (601 S Sherman Street).
F-18 FDG PET scans play a vital role in cancer care and are used throughout the patient journey at Cancer Care Northwest:
Diagnosis: Detects many types of cancers, including lung, lymphoma, colorectal, melanoma, breast, head and neck, and others.
Staging: Determines how far cancer has spread, helping guide treatment decisions.
Treatment Planning: Helps oncologists choose the most appropriate therapies, such as surgery, chemotherapy, or radiation.
Response Evaluation: Measures how effectively a tumor responds to treatment, allowing for timely adjustments if needed.
Recurrence Monitoring: Identifies potential cancer recurrence early—even before symptoms develop.
Tracer: Fluorine-18 fluorodeoxyglucose (FDG), a radioactive form of glucose.
How It Works:
Cancer cells use more glucose than normal cells.
FDG highlights areas with high glucose consumption.
Prep:
Fasting required: At least 6 hours before the exam.
Time Required: Approx. 90 minutes total.
Cancer Care Northwest offers Gallium-68 (GA-68) Dotatate PET/CT scans for the localization of neuroendocrine tumors (NETs) that are somatostatin receptor positive. NET tumors develop most commonly in the lungs, appendix, small intestine, rectum, and pancreas.
Tracer: Gallium-68 Dotatate, an intravaneous tracer which binds to somatostatin receptors.
How It Works:
Prep:
Benefits:
Cancer Care Northwest offers advanced molecular imaging service, Gallium Ga-68 gozetotide injection, also known as Ga-PSMA-11 injection, for prostate cancer. The Ga-PSMA-11 injection is indicated for positron emission tomography (PET) of prostate specific membrane antigen (PSMA) positive lesions in patients with prostate cancer with:
Tracer: Gallium-68 PSMA-11 (Gozetotide), which targets Prostate Specific Membrane Antigen (PSMA).
How It Works:
Prep:
Benefits:
Scan Type |
Fasting Required |
Scan Duration |
Special Instructions |
---|---|---|---|
F-18 FDG PET/CT |
Yes (6 hrs) |
~90 minutes |
Avoid strenuous exercise prior |
Ga-68 Dotatate PET/CT |
No |
~2 hours |
Relax and stay well hydrated |
Ga-PSMA-11 PET/CT |
No |
~90-120 minutes |
Inform staff of recent procedures |
Before the Scan:
After the Scan:
Helpful Handouts:
The American College of Radiology (ACR) has awarded CCNW’s PET/CT Center with its Gold Standard of Accreditation, meaning:
This recognition is given only after a peer-reviewed evaluation by board-certified physicians and medical physicists who are experts in the field.
Contact Cancer Care Northwest or speak with your oncologist about whether a PET/CT is right for you. The CCNW team can help guide you through preparation, what to expect, and how your scan fits into your care plan.